A Phase III Study of Jaktinib in Adults With Moderate and Severe Atopic Dermatitis
Condition(s):Atopic DermatitisLast Updated:September 14, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Atopic DermatitisLast Updated:September 14, 2023Recruiting
Condition(s):Atopic DermatitisLast Updated:August 22, 2017Completed
Condition(s):Atopic DermatitisLast Updated:September 18, 2023Terminated
Condition(s):Atopic DermatitisLast Updated:June 10, 2021Completed
Condition(s):Dermatitis, Atopic; EczemaLast Updated:October 5, 2016Completed
Condition(s):Atopic DermatitisLast Updated:November 8, 2022Terminated
Condition(s):Atopic DermatitisLast Updated:May 6, 2023Enrolling by invitation
Condition(s):Atopic DermatitisLast Updated:September 9, 2022Completed
Condition(s):Atopic Dermatitis; Atopic Dermatitis EczemaLast Updated:February 2, 2024Completed
Condition(s):Atopic DermatitisLast Updated:October 16, 2023Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.